1-93183409-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001378204.1(CCDC18):āc.48A>Cā(p.Glu16Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,605,306 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001378204.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC18 | NM_001378204.1 | c.48A>C | p.Glu16Asp | missense_variant | 2/29 | ENST00000690025.1 | NP_001365133.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC18 | ENST00000690025.1 | c.48A>C | p.Glu16Asp | missense_variant | 2/29 | NM_001378204.1 | ENSP00000510597.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152064Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000101 AC: 25AN: 246490Hom.: 0 AF XY: 0.000127 AC XY: 17AN XY: 133862
GnomAD4 exome AF: 0.000145 AC: 210AN: 1453124Hom.: 0 Cov.: 28 AF XY: 0.000142 AC XY: 103AN XY: 723086
GnomAD4 genome AF: 0.000125 AC: 19AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2024 | The c.48A>C (p.E16D) alteration is located in exon 2 (coding exon 1) of the CCDC18 gene. This alteration results from a A to C substitution at nucleotide position 48, causing the glutamic acid (E) at amino acid position 16 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at